Search results
Author(s):
Tonje Thorvaldsen
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients…
View more
Michael P Jenkins
Author
Felix Ayub Barasa
Author
George D Dangas
Job title: Director of Cardiovascular Innovation
Author
Author(s):
Alexander Fanaroff
Added:
5 months ago
Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of…
View more
Cardiac Risk in the Young (CRY)
Supplier
Sotiris Antoniou
Research Area(s) / Expertise:
Job title: Consultant Pharmacist & Lead Cardiovascular Pharmacist
Author
Morad Sallam
Job title: Consultant Vascular and Endovascular Surgeon
Author
Author(s):
Stefan Spitzer
Added:
2 years ago
Identify which patient groups are most likely to benefit from Atrial Fibrillation ablation and the optimal time for patient referral in this video with Professor Dr Stefan Spitzer.
Key Learning Objectives:
Which patients are likely to benefit most from ablation
When to refer for ablation
Practical guidance for improving access to ablation for relevant patients
Additional Learning…
View more
Foreword
Author(s):
Andrew JS Coats
,
Giuseppe Rosano
Added:
3 years ago
Article